Charaka Medical Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 18-07-2024
- Paid Up Capital ₹ 1.00 M
as on 18-07-2024
- Company Age 3 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
About Charaka Medical Technologies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Venkata Penmetsa and Nageshwar Duvvur serve as directors at the Company.
- CIN/LLPIN
U52100TG2021PTC156884
- Company No.
156884
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Nov 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Charaka Medical Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Penmetsa  | Director | 11-Nov-2021 | Current |
| Nageshwar Duvvur | Director | 11-Nov-2021 | Current |
Financial Performance and Corporate Structure Insights of Charaka Medical Technologies.
Charaka Medical Technologies Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Charaka Medical Technologies?
Unlock access to Charaka Medical Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Prolifics Corporation Private LimitedActive 27 years 26 daysVenkata Penmetsa and Nageshwar Duvvur are mutual person
Asian Institute Of Gastroenterology Private LimitedActive 30 years 3 monthsVenkata Penmetsa and Nageshwar Duvvur are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Charaka Medical Technologies?
Charaka Medical Technologies has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Charaka Medical Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Charaka Medical Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
